Drug and medical device maker Abbott Laboratories said its third-quarter net income dropped 40 percent on costs connected with its purchase of Belgian drugmaker Solvay Pharmaceuticals and its recall of the diabetes drug Meridia.
The ability to reprogram adult somatic cells into induced pluripotent stem cells has created tremendous interest and excitement since they were first generated from mouse and human fibroblasts several years ago.
Cytheris SA announced the initiation of Phase II clinical trial of the company’s investigative immunomodulatory agent CYT107 in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir and the CCR5 inhibitor, maraviroc.
The Pediatric Committee of the European Medicines Agency has adopted an opinion agreeing to Cell Therapeutics, Inc.'s Pixuvri (pixantrone dimaleate) Pediatric Investigation Plan (PIP) for the treatment of lymphoid malignancies and solid tumors in children between ages of 6 months and 18 years.
Research from the first controlled trial of swallowed fluticasone nasal spray (Flonase) on people with eosinophilic esophagitis showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered.
Charles River Laboratories International, Inc. has entered into an agreement with Transposagen Biopharmaceuticals, Inc., to be the exclusive, global provider for Transposagen’s p53 and Bcrp TGEM Knockout Rat Models and associated downstream services utilizing these models
Horizon Discovery Ltd and Cylene Pharmaceuticals, Inc. will utilize Horizon's X-MANTM proprietary human isogenic cancer cell-lines to help identify potential patient benefit from Cylene's novel anticancer agent.
A new study has found and tested in an animal model of Alzheimer’s disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.
A research team has discovered molecular and cellular players in ovaries that control the timing of egg development in mammals.
Phenomenex Inc. announces the addition of two new phases in its Kinetex core-shell HPLC/UHPLC column family; Kinetex XB-C18 and Kinetex C8.
GE Healthcare has introduced Amersham ECL Prime, a highly sensitive reagent characterized by stable signal emission up to three hours after addition of the reagent, which allows for repeated exposures and makes it easier to process several blots in the same experimental run.
New treatments for addiction to heroin or narcotic painkillers promise longer-lasting relief that may remove some day-to-day uncertainty of care.
FDA advisers said that patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.
Tylenol caplets are again being recalled by Johnson & Johnson after some consumers were sickened by ingesting the pills or smelling a musty or moldy odor on the bottles.
Health care giant Johnson & Johnson eked out a 2 percent profit increase in its third quarter, even though sales were down slightly, hurt by repeated product recalls and customer wariness.